162 related articles for article (PubMed ID: 9449242)
1. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
Esquenet M; Swinnen JV; Heyns W; Verhoeven G
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):391-9. PubMed ID: 9449242
[TBL] [Abstract][Full Text] [Related]
2. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
Esquenet M; Swinnen JV; Heyns W; Verhoeven G
Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
[TBL] [Abstract][Full Text] [Related]
3. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells.
Goossens K; Esquenet M; Swinnen JV; Manin M; Rombauts W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):9-18. PubMed ID: 10580834
[TBL] [Abstract][Full Text] [Related]
4. Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells.
Esquenet M; Swinnen JV; Van Veldhoven PP; Denef C; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1997 Dec; 136(1):37-46. PubMed ID: 9510066
[TBL] [Abstract][Full Text] [Related]
5. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
7. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
Esquenet M; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
[TBL] [Abstract][Full Text] [Related]
8. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
Henttu P; Vihko P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):349-60. PubMed ID: 1373297
[TBL] [Abstract][Full Text] [Related]
9. Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells.
Sugimoto K; Simard J; Haagensen DE; Labrie F
J Steroid Biochem Mol Biol; 1994 Nov; 51(3-4):167-74. PubMed ID: 7526888
[TBL] [Abstract][Full Text] [Related]
10. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
11. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.
Langeler EG; van Uffelen CJ; Blankenstein MA; van Steenbrugge GJ; Mulder E
Prostate; 1993; 23(3):213-23. PubMed ID: 7694266
[TBL] [Abstract][Full Text] [Related]
12. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
13. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
14. The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells.
Peng L; Wang J; Malloy PJ; Feldman D
Int J Cancer; 2008 Feb; 122(3):558-66. PubMed ID: 17918155
[TBL] [Abstract][Full Text] [Related]
15. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
Fong CJ; Sutkowski DM; Braun EJ; Bauer KD; Sherwood ER; Lee C; Kozlowski JM
J Urol; 1993 May; 149(5):1190-4. PubMed ID: 7683344
[TBL] [Abstract][Full Text] [Related]
16. Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor.
Li MT; Richter F; Chang C; Irwin RJ; Huang H
BMC Cancer; 2002 Jun; 2():16. PubMed ID: 12069693
[TBL] [Abstract][Full Text] [Related]
17. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.
Henttu P; Liao SS; Vihko P
Endocrinology; 1992 Feb; 130(2):766-72. PubMed ID: 1370795
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of glucuronosyltransferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP.
Guillemette C; Hum DW; Bélanger A
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):225-31. PubMed ID: 8645632
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
